






Company Information
Ask for more detail from the seller
Contact SupplierFOLOTYN is a chemotherapy approved by the US Food & Drug Administration (FDA) for the treatment of relapsed or refractory PTCL. The indication for FOLOTYN is based on overall response rate.
FOLOTYN® is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. The indication for FOLOTYN ® is based on overall .





